Cell Therapy Turnkey Project
I-VEN, ubani ongakusiza ukusethaimboni yokwelapha ngamaselingosekelo lwezobuchwepheshe oluthuthuke kakhulu emhlabeni kanye nokulawulwa kwenqubo okuqeqeshelwe umhlaba wonke.
Ukwelashwa ngamaseli (okubizwa nangokuthi i-cellular therapy, cell transplantation, noma i-cytotherapy) kuwukwelapha lapho amangqamuzana asebenzayo ejovwa khona, axhunyelelwe noma afakwe esigulini ukuze enze umphumela wokwelapha, isibonelo, ngokufakelwa kabusha ama-T-cell akwazi ukulwa namaseli omdlavuza ngokusebenzisa ukungatheleleki kwe-cell-mediated ngesikhathi se-immunotherapy, noma ukuhlunyeleliswa kabusha kwezicubu zesifo.
I-AT cell iwuhlobo lwe-lymphocyte. Amaseli e-T angenye yamangqamuzana egazi amhlophe abalulekile esimiso somzimba sokuzivikela ezifweni futhi adlala indima ebalulekile ekuphenduleni komzimba okuguquguqukayo. Amaseli e-T angahlukaniswa kwamanye ama-lymphocyte ngokuba khona kwe-T-cell receptor (TCR) endaweni yawo yeseli.
I-stem cell therapy iwukwelashwa okungahlanyisi okuhloswe ngayo ukufaka esikhundleni samaseli alimele emzimbeni. Ukwelashwa kwe-mesenchymal stem cell kungasatshalaliswa ngokwesistimu nge-IV noma kujovwe endaweni ukuze kuqondiswe kumasayithi athile, kuye ngezidingo zesiguli.
Ukwelashwa ngamaseli, isikhathi sokwelashwa esifushane esidingekayo ngokululama ngokushesha okukhulu, “njengomuthi ophilayo”, futhi izinzuzo zawo zingahlala iminyaka eminingi.
